Business & FinanceTop StoryTop StoryLatest News
Cipla Q2 Net Profit Falls 35% to ₹878 Cr as US Business Weighs on Sales
Sentiment: NegativeHigh Priority
What Happened?
Cipla reported a 35% year-on-year decline in net profit for Q2 FY27, totaling ₹878 crore, primarily due to lower sales in the US and API sectors. Revenue also fell 2.4% to ₹7,404 crore.
Key points
- Cipla's consolidated net profit for Q2 FY27 is ₹878 crore, down from ₹1,351 crore last year.
- Revenue from operations decreased by 2.4% year-on-year to ₹7,404 crore.
- North America revenue fell 19% year-on-year to $172 million (₹1,643 crore).
- Cipla aims for a $1 billion annual revenue run-rate in North America by FY27.
- The India business grew 12% year-on-year to ₹3,516 crore.
- Revenue from API and other businesses dropped 59% to ₹107 crore.
Key insights
- Cipla's reliance on the US market may pose risks if sales do not recover.
- The growth in the India business indicates potential for domestic market expansion.
- Partnerships and new product launches could help mitigate losses in the US.
Why it matters
The decline in profit and revenue highlights challenges in Cipla's US operations, which could impact future growth.
Tags
Entities
Cipla· CompanyMumbai· CityNorth America· RegionIndia· CountryQilu Pharmaceutical· CompanyKeytruda· Product
Source
Business Standard
